Study: Misuse of acetaminophen combo products in decline

New data suggests there has been a decrease in the incidence of therapeutic misuse of OTC combination products with acetaminophen between 2007 and 2016, according to a study published in Clinical Toxicology.

New data suggests there has been a decrease in the incidence of therapeutic misuse of OTC combination products with acetaminophen between 2007 and 2016, according to a study published in Clinical Toxicology. The study, backed by the Consumer Health Products Association (CHPA), used data from the National Poison Data System to identify when consumers exceeded the maximum dose of an ingredient while using it for its intended purpose for products containing acetaminophen. The total number of therapeutic misuse involving OTC combination products with acetaminophen declined from 8,753 in 2007 to 6,278 in 2016, a 28% drop. Barbara Kochanowski, senior vice president of regulatory and scientific affairs at CHPA, says: "This research provides reassuring evidence that incidents of misuse are rare and continue decreasing. But consumer education is key to continuing this downward trend."